Last week’s Supreme Court decision to invalidate patents on human genes was a win for patients, independent researchers, and even the wider biotech industry.
Last week’s Supreme Court decision to invalidate patents on human genes was a win for patients, independent researchers, and even the wider biotech industry.
Supreme Court says no patenting (natural) genes; brain-computer interfaces mimic motor learning in brain; regenerating finger tips; gene therapy goes deeper; NIH needs more diversity; cross-border collaboration
Scientific publishers come up with a scheme to disseminate publicly funded research in response to a directive from President Obama’s top science advisor.
Democratic Senator Frank Lautenberg of New Jersey, who fought hard against the alcohol and tobacco industries, has passed away.
Was the Human Genome Project the key to a gold mine?
Italian lawmakers have demanded formal approval for a controversial stem-cell therapy, but allowed some patients to continue treatment under stricter rules.
Last week brought scientists one step closer to outlining a plan for the massive government-funded project.
Ten fresh faces will join the panel of experts that helps identify areas of emerging scientific opportunity.
Researchers welcome a new ruling saying that financial holdings will no longer need to be published in an online database.